Current Cancer Drug Targets
Title:Meet Our Editorial Board Member
Volume: 19 Issue: 3
Author(s): M.P. Carty
Affiliation:
Export Options
About this article
Cite this article as:
Carty M.P. , Meet Our Editorial Board Member, Current Cancer Drug Targets 2019; 19 (3) . https://dx.doi.org/10.2174/156800961903190214151927
DOI https://dx.doi.org/10.2174/156800961903190214151927 |
Print ISSN 1568-0096 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5576 |
20
2
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Genetics of the First Seven Proprotein Convertase Enzymes in Health and Disease
Current Genomics EphA2-Dependent Molecular Targeting Therapy for Malignant Tumors
Current Cancer Drug Targets Targeting the AKT Pathway in Glioblastoma
Current Pharmaceutical Design Colon Targeted Liposomal Systems (CTLS): Theranostic Potential
Current Molecular Medicine Lipid Matrix Nanoparticles: Pharmacokinetics and Biopharmaceutics
Current Nanoscience Emerging Targets For Prostate Adenocarcinoma Therapy: How Molecular Biology May Drive Towards a More Tailored Approach
Current Drug Targets Adaptation of Human and Simian Immunodeficiency Viruses for Resistance to Tetherin/BST-2
Current HIV Research Microbial Polysaccharides and their Derivatives as Current and Prospective Pharmaceuticals
Current Pharmaceutical Design Biosystems Engineering of Prokaryotes with Tumor-Killing Capacities
Current Pharmaceutical Design QSAR study on N- (Aryl)-4-(Azolylethyl) Thiazole-5-Carboxamides: Novel Potent Inhibitors of VEGF Receptors I and II
Medicinal Chemistry Radioprotective and Anticancer Efficacies of Ganoderma Lucidum in a Mouse Tumor Model
Current Traditional Medicine New Ketonethiosemicarbazones for Melanogenesis Inhibition
Current Bioactive Compounds Eph Receptors as Drug Targets: Single-Chain Antibodies and Beyond
Current Drug Targets TGF Beta Inhibition for Cancer Therapy
Current Cancer Drug Targets Melanoma and Epigenetic Treatment: Past and Future
Anti-Cancer Agents in Medicinal Chemistry Trends in the Exploration of Anticancer Targets and Strategies in Enhancing the Efficacy of Drug Targeting
Current Molecular Pharmacology Sites of Action of HIV-1 Vpu in BST-2/Tetherin Downregulation
Current HIV Research Animal Models of Systemic Sclerosis
Current Pharmaceutical Design Minor-Groove Binding Agents: Rational Design of Carboxamide Bond Isosteres
Current Topics in Medicinal Chemistry Quercetin as a Systemic Chemopreventative Agent: Structural and Functional Mechanisms
Mini-Reviews in Medicinal Chemistry